ATE400654T1 - Neues säugetiergen bc1-w, welches zur bc1-2 familie apoptose-kontrollierender gene gehört - Google Patents
Neues säugetiergen bc1-w, welches zur bc1-2 familie apoptose-kontrollierender gene gehörtInfo
- Publication number
- ATE400654T1 ATE400654T1 AT97913986T AT97913986T ATE400654T1 AT E400654 T1 ATE400654 T1 AT E400654T1 AT 97913986 T AT97913986 T AT 97913986T AT 97913986 T AT97913986 T AT 97913986T AT E400654 T1 ATE400654 T1 AT E400654T1
- Authority
- AT
- Austria
- Prior art keywords
- family
- present
- therapeutic molecules
- modulating
- bcl
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 241000124008 Mammalia Species 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 abstract 4
- 102000051485 Bcl-2 family Human genes 0.000 abstract 3
- 108700038897 Bcl-2 family Proteins 0.000 abstract 3
- 230000009743 cell cycle entry Effects 0.000 abstract 2
- 150000005829 chemical entities Chemical class 0.000 abstract 2
- 230000004083 survival effect Effects 0.000 abstract 2
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 230000030833 cell death Effects 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002068 genetic effect Effects 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPN8965A AUPN896596A0 (en) | 1996-03-27 | 1996-03-27 | Therapeutic molecules |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE400654T1 true ATE400654T1 (de) | 2008-07-15 |
Family
ID=3793279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97913986T ATE400654T1 (de) | 1996-03-27 | 1997-03-27 | Neues säugetiergen bc1-w, welches zur bc1-2 familie apoptose-kontrollierender gene gehört |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6790637B1 (de) |
| EP (1) | EP0932674B1 (de) |
| JP (1) | JP2000513566A (de) |
| AT (1) | ATE400654T1 (de) |
| AU (1) | AUPN896596A0 (de) |
| CA (1) | CA2250207A1 (de) |
| DE (1) | DE69738822D1 (de) |
| ES (1) | ES2309995T3 (de) |
| WO (1) | WO1997035971A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6001992A (en) * | 1999-01-07 | 1999-12-14 | Isis Pharmaceuticals Inc. | Antisense modulation of novel anti-apoptotic bcl-2-related proteins |
| US5501969A (en) | 1994-03-08 | 1996-03-26 | Human Genome Sciences, Inc. | Human osteoclast-derived cathepsin |
| IL123429A0 (en) | 1998-02-24 | 1998-09-24 | Nst Neurosurvival Technologies | Peptides and pharmaceutical compositions comprising same |
| IL125908A (en) | 1998-08-24 | 2005-05-17 | Nst Neurosurvival Technologies | Peptides and pharmaceutical compositions comprising same |
| IL131266A0 (en) | 1999-08-05 | 2001-01-28 | N S T Neurosurvival Technologi | Peptides and pharmaceutical compositions comprising same |
| HK1042926A1 (zh) * | 1998-10-30 | 2002-08-30 | University Of Nebraska-Lincoln | 细胞凋亡基因的跨种转移和由此产生的转基因植物 |
| US20040266673A1 (en) * | 2002-07-31 | 2004-12-30 | Peter Bakis | Long lasting natriuretic peptide derivatives |
| AUPR552701A0 (en) * | 2001-06-07 | 2001-07-12 | Johnson & Johnson Research Pty. Limited | Bcl-2 dnazymes |
| AU2002953259A0 (en) * | 2002-12-03 | 2003-01-02 | The Walter And Eliza Hall Institute Of Medical Research | Structure |
| WO2007128080A1 (en) * | 2006-05-09 | 2007-11-15 | The Walter And Eliza Hall Institute Of Medical Research | An assay for modulators of apoptosis |
| US20090099074A1 (en) * | 2007-01-10 | 2009-04-16 | Conjuchem Biotechnologies Inc. | Modulating food intake |
| CN101914538A (zh) * | 2010-08-03 | 2010-12-15 | 孙仑泉 | 一种促进肿瘤细胞凋亡的脱氧核酶 |
| JP7368856B2 (ja) | 2017-07-25 | 2023-10-25 | トゥルーバインディング,インコーポレイテッド | Tim-3とそのリガンドとの相互作用の遮断によるがん治療 |
| CN120058944A (zh) | 2019-01-30 | 2025-05-30 | 真和制药有限公司 | 抗gal3抗体及其用途 |
| JP2023528797A (ja) | 2020-05-26 | 2023-07-06 | トゥルーバインディング,インコーポレイテッド | ガレクチン-3を遮断することにより炎症性疾患を処置する方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5015568A (en) | 1986-07-09 | 1991-05-14 | The Wistar Institute | Diagnostic methods for detecting lymphomas in humans |
| US5550019A (en) * | 1993-05-26 | 1996-08-27 | La Jolla Cancer Research Foundation | Methods of identifying compounds which alter apoptosis |
| US5646008A (en) * | 1993-06-22 | 1997-07-08 | The Regent Of The University Of Michigan | Vertebrate apoptosis gene: compositions and methods |
| US5789201A (en) * | 1996-02-23 | 1998-08-04 | Cocensys, Inc. | Genes coding for bcl-y a bcl-2 homologue |
| US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
-
1996
- 1996-03-27 AU AUPN8965A patent/AUPN896596A0/en not_active Abandoned
-
1997
- 1997-03-27 ES ES97913986T patent/ES2309995T3/es not_active Expired - Lifetime
- 1997-03-27 EP EP97913986A patent/EP0932674B1/de not_active Expired - Lifetime
- 1997-03-27 AT AT97913986T patent/ATE400654T1/de not_active IP Right Cessation
- 1997-03-27 DE DE69738822T patent/DE69738822D1/de not_active Expired - Fee Related
- 1997-03-27 JP JP09533874A patent/JP2000513566A/ja not_active Ceased
- 1997-03-27 CA CA002250207A patent/CA2250207A1/en not_active Abandoned
- 1997-03-27 WO PCT/AU1997/000199 patent/WO1997035971A1/en not_active Ceased
- 1997-03-27 US US09/155,327 patent/US6790637B1/en not_active Expired - Fee Related
-
2001
- 2001-08-09 US US09/925,674 patent/US7166698B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0932674B1 (de) | 2008-07-09 |
| EP0932674A1 (de) | 1999-08-04 |
| US20020119943A1 (en) | 2002-08-29 |
| US6790637B1 (en) | 2004-09-14 |
| US7166698B2 (en) | 2007-01-23 |
| CA2250207A1 (en) | 1997-10-02 |
| DE69738822D1 (de) | 2008-08-21 |
| AUPN896596A0 (en) | 1996-04-26 |
| JP2000513566A (ja) | 2000-10-17 |
| WO1997035971A1 (en) | 1997-10-02 |
| ES2309995T3 (es) | 2008-12-16 |
| EP0932674A4 (de) | 2002-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE400654T1 (de) | Neues säugetiergen bc1-w, welches zur bc1-2 familie apoptose-kontrollierender gene gehört | |
| EP1100878B8 (de) | Verfahren zur herstellung von genetisch modifizierten cd34-negativen, adhärent wachsenden hämatopoietischen stammzellen | |
| Kassem | Stem cells: Potential therapy for age‐related diseases | |
| ATE264385T1 (de) | Wachstumsfaktoren und l-glutamin enthaltendes zellkulturmedium | |
| HUP0500477A2 (hu) | Eljárások és készítmények embrionális és felnőttkori őssejtek támogatására stromasejtek alkalmazásával | |
| WO2003066072A3 (en) | Cell therapy using immunoregulatory t-cells | |
| WO2003065999A3 (en) | Proliferated cell lines and uses thereof | |
| BR0014864A (pt) | Métodos de produzir células progenitoras diferenciadas e células tronco embriÈnicas defeituosas em linhagem | |
| NO972171L (no) | Regulering av neural stamcelleproliferasjon | |
| ATE270323T1 (de) | Zusammensetzungen und verfahren zur stimulierung der proliferation und der differenzierung von menschlichen fetalen und erwachsenen pankreatischen zellen ex vivo | |
| O'Connell et al. | Human chondrocyte migration behaviour to guide the development of engineered cartilage | |
| WO2004090096A3 (en) | Methods for neural differentiation of embryonic stem cells using protease passaging techniques | |
| DE60041821D1 (de) | Pluripotent embryonale stammzellen-ähnliche zellen, zusammensetzungen und ihre vervendungen | |
| Herskind | Fibroblast differentiation in subcutaneous fibrosis after postmastectomy radiotherapy | |
| DE69635924D1 (de) | Isolierung und züchtung von schwannzellen | |
| DE69840413D1 (de) | Dna 19355 polypeptide, ein homolog des tumornekrosefaktors | |
| WO2006060709A3 (en) | Biological pathways in progenitor cells | |
| Ye et al. | Comparative study of the osteogenic differentiation capacity of human bone marrow-and human adipose-derived stem cells under cyclic tensile stretch using quantitative analysis | |
| CN109486828A (zh) | 一种编码重组人白细胞介素12的基因及其应用 | |
| WO2003029432A3 (en) | Human mesenchymal progenitor cell | |
| Vasan | Analysis of perinotochordal materials. 2. Studies on the influence of proteoglycans in somite chondrogenesis | |
| ATE527342T1 (de) | Zellkultur mit nm23, nm23 umfassende zellkulturmedien sowie therapeutische verwendung von in gegenwart von nm23 kultivierten zellen | |
| AU8478601A (en) | Methods for culturing human lung mast cells and uses thereof | |
| Hsu et al. | Skin stem cells in health and in disease. | |
| DK1238057T3 (da) | Fremgangsmåde til produktion af vedhæftende dyreceller |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |